TomTex
Designing the future of sustainable biomaterial
New York, United States · Founded 2020 · $4.2M raised
- Headquarters
- New York, New York
- Employees
- 1–10
- Founded
- 2020
- Business Model
- B2B
- Website
- tomtex.co
- Total Funding
- $4.2M
- Last Round
- $2.3M SeedNov 2023
- Rounds
- 2
About
TômTex is a materials innovation company creating a new class of next-generation biomaterials from seashell waste and mycelium (mushrooms). The company's platform technology produces high-performance, 100% biodegradable, and USDA Biobased Certified materials that serve as sustainable alternatives to synthetic and animal leathers. TômTex supplies to fashion designers and brands across North America and Asia, with manufacturing in North America and a focus on circular textile innovation.
Summary
TomTex is a Biotech company based in New York, United States, founded in 2020. It has raised $4.2M in total across 2 rounds, most recently a $2.3M Seed round in Nov 2023. Investors include SOSV, Happiness Ventures and Earth Venture Capital.
Tech & App Stack
1 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Nov 2023
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Green steel company using hydrogen and renewable electricity to decarbonize steel production. For...
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
